Furthermore, recent studies demonstrate that β2M is associated with the regulation of survival, proliferation, and apoptosis in cancer cells, and therefore targeting β2M signaling pathways provides a new strategy for cancer therapeutics4. The gene discussed is B2M; the disease is cancer.